Literature DB >> 10691700

Conjugated enynes as nonaromatic catechol bioisosteres: synthesis, binding experiments, and computational studies of novel dopamine receptor agonists recognizing preferentially the D(3) subtype.

H Hübner1, C Haubmann, W Utz, P Gmeiner.   

Abstract

To evaluate nonaromatic catechol bioisosteres, the conformationally restrained enynes 1 and enediynes 2 were synthesized via palladium-catalyzed coupling as the key reaction step. Subsequent receptor binding studies at the dopamine receptor subtypes D(1), D(2 long), D(2 short), D(3), and D(4) showed highly interesting binding profiles for the enynes 1a and 1b when compared to dopamine. At the guanine nucleotide-sensitive high-affinity binding site of the D(3) receptor, the target compound 1b (K(i) = 5.2 nM) was 10-fold more potent than dopamine but less potent at the D(2) and D(4) subtypes. In contrast to dopamine the agonists 1a and 1b showed strong selectivity for the receptors of the D(2) family (D(2)-D(4)). As far as we know, this study represents the first report on nonaromatic dopamine agonists. Comparison of molecular electrostatic potentials, derived from semiempirical molecular orbital calculations, and lipophilicity maps was performed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10691700     DOI: 10.1021/jm991098z

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  20 in total

1.  Engineering a GPCR-ligand pair that simulates the activation of D(2L) by Dopamine.

Authors:  Nuska Tschammer; Miriam Dörfler; Harald Hübner; Peter Gmeiner
Journal:  ACS Chem Neurosci       Date:  2009-09-24       Impact factor: 4.418

2.  Covalent agonists for studying G protein-coupled receptor activation.

Authors:  Dietmar Weichert; Andrew C Kruse; Aashish Manglik; Christine Hiller; Cheng Zhang; Harald Hübner; Brian K Kobilka; Peter Gmeiner
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-08       Impact factor: 11.205

3.  In Silico Studies Targeting G-protein Coupled Receptors for Drug Research Against Parkinson's Disease.

Authors:  Agostinho Lemos; Rita Melo; Antonio Jose Preto; Jose Guilherme Almeida; Irina Sousa Moreira; Maria Natalia Dias Soeiro Cordeiro
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

4.  Structure-based discovery of opioid analgesics with reduced side effects.

Authors:  Aashish Manglik; Henry Lin; Dipendra K Aryal; John D McCorvy; Daniela Dengler; Gregory Corder; Anat Levit; Ralf C Kling; Viachaslau Bernat; Harald Hübner; Xi-Ping Huang; Maria F Sassano; Patrick M Giguère; Stefan Löber; Grégory Scherrer; Brian K Kobilka; Peter Gmeiner; Bryan L Roth; Brian K Shoichet
Journal:  Nature       Date:  2016-08-17       Impact factor: 49.962

5.  Structure-Based Design and Discovery of New M2 Receptor Agonists.

Authors:  Inbar Fish; Anne Stößel; Katrin Eitel; Celine Valant; Sabine Albold; Harald Huebner; Dorothee Möller; Mary J Clark; Roger K Sunahara; Arthur Christopoulos; Brian K Shoichet; Peter Gmeiner
Journal:  J Med Chem       Date:  2017-11-13       Impact factor: 7.446

6.  Structure-based evolution of subtype-selective neurotensin receptor ligands.

Authors:  Carolin Schaab; Ralf Christian Kling; Jürgen Einsiedel; Harald Hübner; Tim Clark; Dieter Seebach; Peter Gmeiner
Journal:  ChemistryOpen       Date:  2014-09-23       Impact factor: 2.911

7.  Iodination of carbohydrate-derived 1,2-oxazines to enantiopure 5-iodo-3,6-dihydro-2H-1,2-oxazines and subsequent palladium-catalyzed cross-coupling reactions.

Authors:  Michal Medvecký; Igor Linder; Luise Schefzig; Hans-Ulrich Reissig; Reinhold Zimmer
Journal:  Beilstein J Org Chem       Date:  2016-12-29       Impact factor: 2.883

8.  In vivo monitoring of the antiangiogenic effect of neurotensin receptor-mediated radiotherapy by small-animal positron emission tomography: a pilot study.

Authors:  Simone Maschauer; Tina Ruckdeschel; Philipp Tripal; Roland Haubner; Jürgen Einsiedel; Harald Hübner; Peter Gmeiner; Torsten Kuwert; Olaf Prante
Journal:  Pharmaceuticals (Basel)       Date:  2014-04-16

9.  Structure-guided development of heterodimer-selective GPCR ligands.

Authors:  Harald Hübner; Tamara Schellhorn; Marie Gienger; Carolin Schaab; Jonas Kaindl; Laurin Leeb; Timothy Clark; Dorothee Möller; Peter Gmeiner
Journal:  Nat Commun       Date:  2016-07-26       Impact factor: 14.919

10.  Visualization and ligand-induced modulation of dopamine receptor dimerization at the single molecule level.

Authors:  Alina Tabor; Siegfried Weisenburger; Ashutosh Banerjee; Nirupam Purkayastha; Jonas M Kaindl; Harald Hübner; Luxi Wei; Teja W Grömer; Johannes Kornhuber; Nuska Tschammer; Nigel J M Birdsall; Gregory I Mashanov; Vahid Sandoghdar; Peter Gmeiner
Journal:  Sci Rep       Date:  2016-09-12       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.